NCT05595889 2022-11-29
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 2 Unknown
Fujian Cancer Hospital
Sun Yat-sen University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology